基于AI方法的联盟使用真实世界临床数据预测乳腺癌15年转移风险,AUC高达0.9
Coalitions of AI-based Methods Predict 15-Year Risks of Breast Cancer Metastasis Using Real-World Clinical Data with AUC up to 0.9
AI总结:
该研究利用机器学习结合网格搜索和贝叶斯网络,基于现有临床与组织病理学数据,开发了预测乳腺癌15年转移风险的算法,AUC达0.9,为精准预后提供了快速可转化的方案。
摘要:
乳腺癌是导致女性死亡最多的两种癌症之一,每年在美国造成约42,000人死亡。每年新诊断出超过300,000例乳腺癌,这表明只有一部分癌症会导致死亡。因此,大多数女性接受了针对局部癌症的看似治愈性的治疗,但后来有相当一部分人死于转移性疾病,对于绝大多数人来说,目前的治疗只能暂时缓解。目前的预后指标对于5名看似在局部治疗后治愈的女性中的4名几乎没有可操作的价值,许多女性不必要地暴露于病态甚至致命的辅助治疗中,而这些辅助治疗仅将转移复发减少了三分之一。因此,需要更好的预后方法,将积极治疗针对可能复发的患者,并放过那些真正治愈的患者。虽然目前有大量正在使用和开发中的分子和肿瘤标志物检测用于早期发现复发,但这些方法耗时、昂贵,且在可操作的预后效用方面通常仍未得到验证。另一种方法是使用大数据技术确定临床和组织病理学参数,利用现有数据提供准确的预后。在此,我们报告了机器学习结合网格搜索和贝叶斯网络,开发出在ROC分析中AUC高达0.9的算法,仅使用现有数据。这些算法可以快速转化为临床管理,因为它们不需要超越常规肿瘤评估的测试。
英文摘要:
Breast cancer is one of the two cancers responsible for the most deaths in women, with about 42,000 deaths each year in the US. That there are over 300,000 breast cancers newly diagnosed each year suggests that only a fraction of the cancers result in mortality. Thus, most of the women undergo seemingly curative treatment for localized cancers, but a significant later succumb to metastatic disease for which current treatments are only temporizing for the vast majority. The current prognostic metrics are of little actionable value for 4 of the 5 women seemingly cured after local treatment, and many women are exposed to morbid and even mortal adjuvant therapies unnecessarily, with these adjuvant therapies reducing metastatic recurrence by only a third. Thus, there is a need for better prognostics to target aggressive treatment at those who are likely to relapse and spare those who were actually cured. While there is a plethora of molecular and tumor-marker assays in use and under-development to detect recurrence early, these are time consuming, expensive and still often un-validated as to actionable prognostic utility. A different approach would use large data techniques to determine clinical and histopathological parameters that would provide accurate prognostics using existing data. Herein, we report on machine learning, together with grid search and Bayesian Networks to develop algorithms that present a AUC of up to 0.9 in ROC analyses, using only extant data. Such algorithms could be rapidly translated to clinical management as they do not require testing beyond routine tumor evaluations.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。